首页> 美国卫生研究院文献>AAPS PharmSciTech >Controlled Release Matrix Tablets of Zidovudine: Effect of Formulation Variables on the In Vitro Drug Release Kinetics
【2h】

Controlled Release Matrix Tablets of Zidovudine: Effect of Formulation Variables on the In Vitro Drug Release Kinetics

机译:齐多夫定的控释基质片剂:制剂变量对体外药物释放动力学的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this research was to design oral controlled release (CR) matrix tablets of zidovudine (AZT) using hydroxypropyl methylcellulose (HPMC), ethyl cellulose (EC) and carbopol-971P (CP) and to study the effect of various formulation factors on in vitro drug release. Release studies were carried out using USP type 1 apparatus in 900 ml of dissolution media. Release kinetics were analyzed using zero-order, Higuchi’s square root and Ritger–Peppas’ empirical equations. Release rate decreased with increase in polymer proportion and compression force. The release rate was lesser in formulations prepared using CP (20%) as compared to HPMC (20%) as compared to EC (20%). No significant difference was observed in the effect of pH of dissolution media on drug release from formulations prepared using HPMC or EC, but significant difference was observed in CP based formulations. Decrease in agitation speed from 100 to 50 rpm decreased release rate from HPMC and CP formulations but no significant difference was observed in EC formulations. Mechanism of release was found to be dependent predominantly on diffusion of drug through the matrix than polymer relaxation incase of HPMC and EC formulations, while polymer relaxation had a dominating influence on drug release than diffusion incase of CP formulations. Designed CR tablets with pH independent drug release characteristics and an initial release of 17–25% in first hour and extending the release up to 16–20 h, can overcome the disadvantages associated with conventional tablets of AZT.
机译:这项研究的目的是设计使用羟丙基甲基纤维素(HPMC),乙基纤维素(EC)和carbopol-971P(CP)的齐多夫定(AZT)口服控释(CR)基质片剂,并研究各种制剂因素对体外药物释放。使用USP 1型仪器在900毫升溶出介质中进行释放研究。使用零阶,Higuchi的平方根和Ritger-Peppas的经验方程式分析了释放动力学。释放速率随聚合物比例和压缩力的增加而降低。与HPMC(20%)相比,使用CP(20%)制备的制剂的释放速率低于EC(20%)。在使用HPMC或EC制备的制剂中,溶解介质的pH值对药物释放的影响未观察到显着差异,但在基于CP的制剂中观察到显着差异。搅拌速度从100 rpm降低到50 rpm可降低HPMC和CP配方的释放速率,但在EC配方中未观察到显着差异。在HPMC和EC制剂的情况下,发现释放机理主要取决于药物通过基质的扩散,而不是聚合物松弛,而在CP制剂的情况下,聚合物松弛对药物释放的影响大于扩散。设计具有pH无关药物释放特性的CR片剂,第一个小时的初始释放量为17-25%,并将释放时间延长至16-20h,可以克服与AZT常规片剂相关的缺点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号